DE69631786D1 - Über die lungen verabreichbares trockenpulver alpha 1-antitrypsin - Google Patents
Über die lungen verabreichbares trockenpulver alpha 1-antitrypsinInfo
- Publication number
- DE69631786D1 DE69631786D1 DE69631786T DE69631786T DE69631786D1 DE 69631786 D1 DE69631786 D1 DE 69631786D1 DE 69631786 T DE69631786 T DE 69631786T DE 69631786 T DE69631786 T DE 69631786T DE 69631786 D1 DE69631786 D1 DE 69631786D1
- Authority
- DE
- Germany
- Prior art keywords
- alpha
- dry powder
- lung
- antitrypsin
- powder available
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/07—General characteristics of the apparatus having air pumping means
- A61M2205/071—General characteristics of the apparatus having air pumping means hand operated
- A61M2205/073—Syringe, piston type
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/423,515 US6582728B1 (en) | 1992-07-08 | 1995-04-14 | Spray drying of macromolecules to produce inhaleable dry powders |
US423515 | 1995-04-14 | ||
US08/617,512 US5780014A (en) | 1995-04-14 | 1996-03-13 | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US617512 | 1996-03-13 | ||
PCT/US1996/005062 WO1996032152A1 (en) | 1995-04-14 | 1996-04-11 | Pulmonary administration of dry powder alpha 1-antitrypsin |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69631786D1 true DE69631786D1 (de) | 2004-04-08 |
DE69631786T2 DE69631786T2 (de) | 2005-03-10 |
DE69631786T3 DE69631786T3 (de) | 2008-07-24 |
Family
ID=27026029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69631786T Expired - Lifetime DE69631786T3 (de) | 1995-04-14 | 1996-04-11 | Über die lungen verabreichbares trockenpulver alpha 1-antitrypsin |
Country Status (12)
Country | Link |
---|---|
US (2) | US5780014A (de) |
EP (1) | EP0866726B2 (de) |
JP (1) | JPH10509738A (de) |
KR (1) | KR100430125B1 (de) |
AT (1) | ATE260688T1 (de) |
AU (1) | AU703491B2 (de) |
BR (1) | BR9609497A (de) |
CA (1) | CA2218208A1 (de) |
DE (1) | DE69631786T3 (de) |
ES (1) | ES2217309T5 (de) |
MX (1) | MX9707854A (de) |
WO (1) | WO1996032152A1 (de) |
Families Citing this family (147)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
KR100449789B1 (ko) | 1996-01-24 | 2005-02-03 | 알타나 파마 아게 | 분말형폐계면활성제제의제조방법 |
US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US6652837B1 (en) | 1996-05-24 | 2003-11-25 | Massachusetts Institute Of Technology | Preparation of novel particles for inhalation |
US6458574B1 (en) | 1996-09-12 | 2002-10-01 | Transkaryotic Therapies, Inc. | Treatment of a α-galactosidase a deficiency |
US6083725A (en) * | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US20010006939A1 (en) * | 1997-10-03 | 2001-07-05 | Ralph W. Niven | Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
US6541606B2 (en) | 1997-12-31 | 2003-04-01 | Altus Biologics Inc. | Stabilized protein crystals formulations containing them and methods of making them |
WO1999055310A1 (en) | 1998-04-27 | 1999-11-04 | Altus Biologics Inc. | Stabilized protein crystals, formulations containing them and methods of making them |
GB9808802D0 (en) * | 1998-04-24 | 1998-06-24 | Glaxo Group Ltd | Pharmaceutical formulations |
US6391861B1 (en) | 1998-05-14 | 2002-05-21 | The Trustees Of Columbia University In The City Of New York | Method for the prevention of tissue elastic fiber injury |
US6593133B1 (en) | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
US6956021B1 (en) * | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
US20020006901A1 (en) * | 1999-02-05 | 2002-01-17 | Aldo T. Iacono | Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease |
US6630121B1 (en) | 1999-06-09 | 2003-10-07 | The Regents Of The University Of Colorado | Supercritical fluid-assisted nebulization and bubble drying |
US20010036481A1 (en) * | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
CA2382821A1 (en) * | 1999-08-25 | 2001-03-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
US6749835B1 (en) | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
US20010029947A1 (en) * | 1999-12-17 | 2001-10-18 | Steve Paboojian | Receptacles to facilitate the extraction of powders |
KR20020072563A (ko) * | 1999-12-30 | 2002-09-16 | 인터뮨, 인크. | γ―IFN 액체―소적 에어로졸 및 방법 |
ES2327606T3 (es) | 2000-01-10 | 2009-11-02 | Maxygen Holdings Ltd | Conjugados de g-csf. |
US20010036454A1 (en) * | 2000-02-17 | 2001-11-01 | Chester Li | Genetic modification of the lung as a portal for gene delivery |
US7442388B2 (en) | 2000-05-10 | 2008-10-28 | Weers Jeffry G | Phospholipid-based powders for drug delivery |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US6668827B2 (en) * | 2000-05-16 | 2003-12-30 | Nektar Therapeutics | Systems devices and methods for opening receptacles having a powder to be fluidized |
EP1292314A2 (de) * | 2000-05-23 | 2003-03-19 | The Trustees of Columbia University in the City of New York | Methode zur behandlung von krankheiten der atemwege durch einsatz von glycosaminoglycane |
GB2362884A (en) * | 2000-05-30 | 2001-12-05 | Isis Innovation | Extended duration of airway gene therapy |
DE10043509A1 (de) * | 2000-09-01 | 2002-03-14 | Asta Medica Ag | Feste Peptidzubereitungen für die Inhalation und deren Herstellung |
WO2002032406A2 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
US20020141946A1 (en) * | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
US7442370B2 (en) | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
ATE432288T1 (de) | 2001-02-27 | 2009-06-15 | Maxygen Aps | Neue interferon-beta-ähnliche moleküle |
US7276580B2 (en) * | 2001-03-12 | 2007-10-02 | Biogen Idec Ma Inc. | Neurotrophic factors |
US6887462B2 (en) | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
USD476731S1 (en) | 2001-08-27 | 2003-07-01 | Kimberly-Clark Worldwide, Inc. | Bendable connector |
USD473941S1 (en) | 2001-08-27 | 2003-04-29 | Kimberly-Clark Worldwide, Inc. | Flexible connecting device |
USD466607S1 (en) | 2001-08-27 | 2002-12-03 | Kimberly-Clark Worldwide, Inc. | Flexible connector |
USD486909S1 (en) | 2001-08-27 | 2004-02-17 | Kimberly-Clark Worldwide, Inc. | Bendable connecting device |
US7182961B2 (en) * | 2001-11-20 | 2007-02-27 | Advanced Inhalation Research, Inc. | Particulate compositions for pulmonary delivery |
WO2003043603A1 (en) * | 2001-11-20 | 2003-05-30 | Advanced Inhalation Research, Inc. | Particulate compositions for improving solubility of poorly soluble agents |
CA2468958C (en) | 2001-12-19 | 2012-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
US7378438B2 (en) * | 2002-04-19 | 2008-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
EP1503788B1 (de) | 2002-04-25 | 2011-06-29 | Shire Human Genetic Therapies, Inc. | Behandlung des alpha-galactosidase a mangels |
EP1551852A4 (de) * | 2002-04-25 | 2007-03-21 | Momenta Pharmaceuticals Inc | Verfahren und produkte zur verabreichung an die schleimhaut |
US6889690B2 (en) | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
US7118010B2 (en) | 2002-05-10 | 2006-10-10 | Oriel Therapeutics, Inc. | Apparatus, systems and related methods for dispensing and /or evaluating dry powders |
US7677411B2 (en) | 2002-05-10 | 2010-03-16 | Oriel Therapeutics, Inc. | Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders |
US6985798B2 (en) | 2002-05-10 | 2006-01-10 | Oriel Therapeutics, Inc. | Dry powder dose filling systems and related methods |
AU2003251760A1 (en) | 2002-06-27 | 2004-01-19 | Oriel Therapeutics, Inc. | Apparatus and methods for dispensing dry powders |
AU2003278565A1 (en) * | 2002-10-25 | 2004-05-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
JP4571776B2 (ja) * | 2002-11-05 | 2010-10-27 | Jx日鉱日石エネルギー株式会社 | 潤滑油組成物 |
US7777006B2 (en) | 2002-12-31 | 2010-08-17 | Csl Behring L.L.C. | Method for purification of alpha-1-antitrypsin |
HUE033381T2 (en) | 2003-01-31 | 2017-11-28 | Mount Sinai School Of Medicine Of New York Univ | Combination therapy for the treatment of protein deficiency disorders |
US20040170214A1 (en) * | 2003-02-27 | 2004-09-02 | Richard Rund | Food safety thermometer |
EP1897552B1 (de) | 2003-04-18 | 2009-06-17 | Biogen Idec MA Inc. | Polymerkonjugiertes glycosiliertes Neublastin |
AU2004240629B2 (en) * | 2003-05-16 | 2010-02-25 | Arriva Pharmaceuticals, Inc. | Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors |
CN1826170B (zh) * | 2003-07-18 | 2010-12-08 | 巴克斯特国际公司 | 通过受控相分离制备的小球形颗粒的制造方法、其用途和成分 |
EP1660661A2 (de) | 2003-08-08 | 2006-05-31 | Arriva Pharmaceuticals, Inc. | Verfahren zur proteinproduktion in hefe |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
WO2005032483A2 (en) * | 2003-10-01 | 2005-04-14 | Momenta Pharmaceuticals, Inc. | Polysaccharides for pulmonary delivery of active agents |
US7377277B2 (en) | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
JP2007534633A (ja) * | 2003-11-10 | 2007-11-29 | アライバ−プロメティック インコーポレイティド | ヒト・アルファ1−抗トリプシン製剤 |
WO2005049801A2 (en) * | 2003-11-14 | 2005-06-02 | Arriva Pharmaceuticals, Inc. | Dry protein formulation |
CA2545855A1 (en) * | 2003-11-14 | 2005-06-02 | Baxter International Inc. | Alpha 1-antitrypsin compositions and treatment methods using such compositions |
US7914771B2 (en) | 2004-03-09 | 2011-03-29 | Arriva Pharmaceuticals, Inc. | Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor |
EP2289911A3 (de) | 2004-03-30 | 2011-03-30 | NsGene A/S | Therapeutische Verwendung des Wachstumsfaktors nsg33 |
CN101027318B (zh) | 2004-07-19 | 2016-05-25 | 比奥孔有限公司 | 胰岛素-低聚物共轭物,制剂及其用途 |
US20090136552A1 (en) * | 2004-07-30 | 2009-05-28 | Mette Gronborg | Growth factors nsg28, nsg30, and nsg32 |
MX2007002029A (es) * | 2004-08-19 | 2007-03-28 | Biogen Idec Inc | Variantes de neublastina. |
AU2005277227B2 (en) | 2004-08-19 | 2011-10-06 | Biogen Ma Inc. | Refolding transforming growth factor beta family proteins |
US20070105768A1 (en) * | 2004-11-10 | 2007-05-10 | Rajiv Nayar | Dry recombinant human alpha 1-antitrypsin formulation |
UA95446C2 (ru) | 2005-05-04 | 2011-08-10 | Іллюміджен Байосайєнсіз, Інк. | Мутаци в генах oas1 |
EP3782655A1 (de) | 2005-05-17 | 2021-02-24 | Amicus Therapeutics, Inc. | Verfahren zur behandlung der pompe-krankheit unter verwendung von 1-deoxynojirimycin und derivaten |
US20100119525A1 (en) * | 2005-08-01 | 2010-05-13 | Mount Sinai Schoool Of Medicine Of New York University | Method for extending longevity using npc1l1 antagonists |
WO2007019554A2 (en) * | 2005-08-08 | 2007-02-15 | Momenta Pharmaceuticals, Inc. | Polysaccharides for delivery of active agents |
US8000981B2 (en) | 2005-11-30 | 2011-08-16 | The Invention Science Fund I, Llc | Methods and systems related to receiving nutraceutical associated information |
US8340944B2 (en) | 2005-11-30 | 2012-12-25 | The Invention Science Fund I, Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US7927787B2 (en) | 2006-06-28 | 2011-04-19 | The Invention Science Fund I, Llc | Methods and systems for analysis of nutraceutical associated components |
US10296720B2 (en) | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
US20080103746A1 (en) | 2005-11-30 | 2008-05-01 | Searete Llc, A Limited Liability Corporation | Systems and methods for pathogen detection and response |
US8297028B2 (en) | 2006-06-14 | 2012-10-30 | The Invention Science Fund I, Llc | Individualized pharmaceutical selection and packaging |
US7827042B2 (en) | 2005-11-30 | 2010-11-02 | The Invention Science Fund I, Inc | Methods and systems related to transmission of nutraceutical associated information |
US7974856B2 (en) | 2005-11-30 | 2011-07-05 | The Invention Science Fund I, Llc | Computational systems and methods related to nutraceuticals |
WO2007102946A2 (en) | 2006-01-23 | 2007-09-13 | Amgen Inc. | Crystalline polypeptides |
JP2009528295A (ja) | 2006-02-24 | 2009-08-06 | ライジェル ファーマシューティカルズ, インコーポレイテッド | Jak経路の阻害のための組成物および方法 |
TWI501774B (zh) | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
US20100056440A1 (en) * | 2006-03-01 | 2010-03-04 | Biogen Idec Ma Inc. | Compositions and methods for administering gdnf ligand family proteins |
CA2685686A1 (en) | 2007-05-01 | 2008-11-13 | Biogen Idec Ma Inc. | Neublastin polypeptides for use increasing vascularization in a tissue |
WO2009020964A2 (en) * | 2007-08-08 | 2009-02-12 | Biogen Idec Ma Inc. | Anti-neublastin antibodies and uses thereof |
CN101778860B (zh) | 2007-08-17 | 2013-07-10 | Csl百灵有限公司 | α-1-抗胰蛋白酶和载脂蛋白A-I的纯化方法 |
US8273561B2 (en) | 2007-10-05 | 2012-09-25 | Nuron Biotech, Inc. | High pressure treatment of aggregated interferons |
ES2473584T3 (es) | 2009-01-23 | 2014-07-07 | Rigel Pharmaceuticals, Inc. | Composiciones y métodos para la inhibición de la ruta de JAK |
AU2010233188B2 (en) | 2009-04-09 | 2015-07-16 | Amicus Therapeutics, Inc. | Methods for preventing and/or treating lysosomal storage disorders |
WO2010142017A1 (en) | 2009-06-09 | 2010-12-16 | Defyrus, Inc . | Administration of interferon for prophylaxis against or treatment of pathogenic infection |
WO2011008737A2 (en) | 2009-07-13 | 2011-01-20 | The University Of North Carolina At Chapel Hill | Engineered aerosol particles, and associated methods |
HUE041971T2 (hu) | 2009-10-19 | 2019-06-28 | Amicus Therapeutics Inc | Új készítmények lizoszomális tárolási rendellenességek kezelésére és/vagy megelõzésére |
CN102655747A (zh) | 2009-10-19 | 2012-09-05 | 阿米库斯治疗学公司 | 用于预防和/或治疗中枢神经系统退行性失调的新颖组合物 |
JP2013518097A (ja) | 2010-01-26 | 2013-05-20 | イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー | 肺高血圧を予防および治療するための組成物および方法 |
WO2011157275A1 (en) | 2010-06-14 | 2011-12-22 | H. Lundbeck A/S | Modulation of the interaction between sorla and gdnf-family ligand receptors |
CA2754237A1 (en) | 2011-05-27 | 2012-11-27 | The Regents Of The University Of California | Cyanoquinoline compounds having activity in correcting mutant-cftr processing and increasing ion transport and uses thereof |
US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
CN103889436A (zh) | 2011-12-30 | 2014-06-25 | 基立福有限公司 | 用于延迟肺部症状加重的发作或进展的α1-蛋白酶抑制剂 |
US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
US20150010527A1 (en) | 2012-02-01 | 2015-01-08 | Protalix Ltd. | Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy |
JP6231548B2 (ja) | 2012-03-23 | 2017-11-15 | マテオン セラピューティクス, インコーポレイテッド | カテプシンの阻害のための組成物および方法 |
EP2831043B1 (de) | 2012-03-27 | 2022-07-27 | Amicus Therapeutics, Inc. | Neuartige verbindungen zur prophylaxe und/oder behandlung lysosomaler speicherkrankheiten und/oder degenerativer erkrankungen des zentralen nervensystems |
EA201492055A1 (ru) | 2012-06-08 | 2015-11-30 | Шир Хьюман Дженетик Терапис, Инк. | ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ |
EA201691603A1 (ru) | 2014-02-12 | 2016-11-30 | Амикус Терапьютикс, Инк. | Производные сахаров, содержащие серосодержащие фрагменты, способы их получения и способы их применения для лечения mps iiic |
US9675627B2 (en) | 2014-04-14 | 2017-06-13 | Amicus Therapeutics, Inc. | Dosing regimens for treating and/or preventing cerebral amyloidoses |
US20170304459A1 (en) | 2014-10-10 | 2017-10-26 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for inhalation delivery of conjugated oligonucleotide |
CA2965759C (en) | 2014-10-31 | 2023-12-12 | Glaxosmithkline Intellectual Property Development Limited | Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials |
SG11201707663SA (en) | 2015-04-17 | 2017-11-29 | Curevac Ag | Lyophilization of rna |
EP3297682B1 (de) | 2015-05-20 | 2021-07-14 | CureVac AG | Trockenpulverzusammensetzung mit langkettiger rna |
CN107635587A (zh) | 2015-05-20 | 2018-01-26 | 库瑞瓦格股份公司 | 包含长链rna的干燥粉末组合物 |
US10179128B2 (en) | 2015-08-31 | 2019-01-15 | Amicus Therapeutics, Inc. | Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system |
NL2017294B1 (en) | 2016-08-05 | 2018-02-14 | Univ Erasmus Med Ct Rotterdam | Natural cryptic exon removal by pairs of antisense oligonucleotides. |
WO2018116300A1 (en) * | 2016-12-22 | 2018-06-28 | Kamada Ltd. | Dry powder formulations of alpha-1 antitrypsin |
JP6868698B2 (ja) | 2016-12-31 | 2021-05-12 | バイオエクセル セラピューティクス,インコーポレイテッド | 激越の治療のための舌下デクスメデトミジンの使用 |
CA3061354A1 (en) | 2017-04-25 | 2018-11-01 | Amicus Therapeutics, Inc. | Novel compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders |
MX2020014000A (es) | 2018-06-27 | 2021-06-15 | Bioxcel Therapeutics Inc | Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas. |
US11160791B2 (en) | 2018-11-01 | 2021-11-02 | Medefil, Inc. | Dexmedetomidine injection premix formulation in ready to use (RTU) bags |
US20220000880A1 (en) | 2018-11-01 | 2022-01-06 | Rigel Pharmaceuticals, Inc. | Method and composition embodiments for treating acute myeloid leukemia |
EP3956303A1 (de) | 2019-04-18 | 2022-02-23 | Translate Bio, Inc. | Kationische cystin-enthaltende lipide |
ES2972014T3 (es) | 2019-04-22 | 2024-06-10 | Translate Bio Inc | Lípidos catiónicos de tioéster |
US20220257724A1 (en) | 2019-05-03 | 2022-08-18 | Translate Bio, Inc. | Di-thioester cationic lipids |
US20200377518A1 (en) | 2019-05-29 | 2020-12-03 | Rigel Pharmaceuticals, Inc. | Method of preventing and treating thrombosis |
EP3976593A1 (de) | 2019-05-31 | 2022-04-06 | Translate Bio, Inc. | Makrocyclische lipide |
BR112022000992A2 (pt) | 2019-07-19 | 2022-06-14 | Arx Llc | Regimes de tratamento de dexmedetomidina não sedantes |
MX2022001596A (es) | 2019-08-08 | 2022-03-11 | Rigel Pharmaceuticals Inc | Compuestos y metodos para tratar sindrome de liberacion de citocinas. |
EP4013420B1 (de) | 2019-08-14 | 2023-11-01 | Rigel Pharmaceuticals, Inc. | Verfahren zur blockierung oder linderung des zytokinfreisetzungssyndroms |
JP2023520047A (ja) | 2020-04-01 | 2023-05-15 | トランスレイト バイオ, インコーポレイテッド | フェノール酸脂質系カチオン性脂質 |
WO2022066678A1 (en) | 2020-09-23 | 2022-03-31 | Translate Bio, Inc. | Tes-based cationic lipids |
EP4216933A1 (de) | 2020-09-23 | 2023-08-02 | Translate Bio, Inc. | Kationische lipide auf piperazinbasis |
TW202309002A (zh) | 2021-04-15 | 2023-03-01 | 美商轉譯生技公司 | 基於「古德」緩衝液的陽離子脂質 |
WO2023178167A1 (en) | 2022-03-16 | 2023-09-21 | Translate Bio, Inc. | Asymmetric piperazine-based cationic lipids |
TW202346291A (zh) | 2022-03-23 | 2023-12-01 | 美商雷傑製藥公司 | 作為irak抑制劑的嘧啶—2—基—吡唑化合物 |
WO2023198857A1 (en) | 2022-04-13 | 2023-10-19 | Sanofi | "good" buffer-based cationic lipids |
US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2598525A (en) * | 1950-04-08 | 1952-05-27 | E & J Mfg Co | Automatic positive pressure breathing machine |
US3362405A (en) * | 1964-04-06 | 1968-01-09 | Hamilton O. Hazel | Method and apparatus for admixing gas with solid particles |
US3425600A (en) * | 1966-08-11 | 1969-02-04 | Abplanalp Robert H | Pressurized powder dispensing device |
US4069819A (en) * | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
GB1479283A (en) * | 1973-07-23 | 1977-07-13 | Bespak Industries Ltd | Inhaler for powdered medicament |
FR2257351A1 (en) * | 1974-01-11 | 1975-08-08 | Obert Jean Claude | Aerosol device for solid vaccines - feed and breaker screws deliver material sideways into blower chamber |
IT1016489B (it) * | 1974-03-18 | 1977-05-30 | Isf Spa | Inalatore |
SU628930A1 (ru) * | 1974-11-26 | 1978-10-25 | Московский научно-исследовательский институт туберкулеза | Устройство дл введени порошкообразного лекарственного вещества |
US3964483A (en) * | 1975-01-13 | 1976-06-22 | Syntex Puerto Rico, Inc. | Inhalation device |
US4005711A (en) * | 1975-01-13 | 1977-02-01 | Syntex Puerto Rico, Inc. | Inhalation device |
FR2299011A1 (fr) * | 1975-01-29 | 1976-08-27 | Obert Jean Claude | Generateur d'aerosols de part |
US3991304A (en) * | 1975-05-19 | 1976-11-09 | Hillsman Dean | Respiratory biofeedback and performance evaluation system |
US4153689A (en) * | 1975-06-13 | 1979-05-08 | Takeda Chemical Industries, Ltd. | Stable insulin preparation for nasal administration |
GB1527605A (en) * | 1975-08-20 | 1978-10-04 | Takeda Chemical Industries Ltd | Insulin preparation for intranasal administration |
US3994421A (en) * | 1975-09-29 | 1976-11-30 | American Cyanamid Company | Unitary therapeutic aerosol dispenser |
NL7712041A (en) * | 1977-11-01 | 1979-05-03 | Handelmaatschappij Voorheen Be | Suction equipment for powdery material - incorporates ejector type suction pump and cyclone type separator |
EP0005585B1 (de) * | 1978-05-03 | 1981-08-12 | FISONS plc | Inhalationsvorrichtung |
US4253468A (en) * | 1978-08-14 | 1981-03-03 | Steven Lehmbeck | Nebulizer attachment |
US4503035B1 (en) * | 1978-11-24 | 1996-03-19 | Hoffmann La Roche | Protein purification process and product |
SU1003926A1 (ru) * | 1979-01-24 | 1983-03-15 | Всесоюзный Научно-Исследовательский И Конструкторский Институт Автогенного Машиностроения | Порошковый питатель |
IT1116047B (it) * | 1979-04-27 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma |
JPS6034925B2 (ja) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
NL8020393A (de) * | 1979-10-30 | 1981-09-01 | Riker Laboratories, Inc. Te Loughborough, Groot-Brittannie. | |
US4452239A (en) * | 1980-03-25 | 1984-06-05 | Hilal Malem | Medical nebulizing apparatus |
US4484577A (en) * | 1981-07-23 | 1984-11-27 | Key Pharmaceuticals, Inc. | Drug delivery method and inhalation device therefor |
US5260306A (en) * | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
US4823784A (en) * | 1982-04-30 | 1989-04-25 | Cadema Medical Products, Inc. | Aerosol inhalation apparatus |
US4599311A (en) * | 1982-08-13 | 1986-07-08 | Kawasaki Glenn H | Glycolytic promotersfor regulated protein expression: protease inhibitor |
GR79615B (de) * | 1982-10-08 | 1984-10-31 | Glaxo Group Ltd | |
US4649911A (en) * | 1983-09-08 | 1987-03-17 | Baylor College Of Medicine | Small particle aerosol generator for treatment of respiratory disease including the lungs |
DE3345722A1 (de) * | 1983-12-17 | 1985-06-27 | Boehringer Ingelheim KG, 6507 Ingelheim | Inhalator |
US4534343A (en) * | 1984-01-27 | 1985-08-13 | Trutek Research, Inc. | Metered dose inhaler |
US4624251A (en) * | 1984-09-13 | 1986-11-25 | Riker Laboratories, Inc. | Apparatus for administering a nebulized substance |
NZ209900A (en) * | 1984-10-16 | 1989-08-29 | Univ Auckland | Automatic inhaler |
FR2575678B1 (fr) * | 1985-01-04 | 1988-06-03 | Saint Gobain Vitrage | Ejecteur pneumatique de poudre |
US4942544A (en) * | 1985-02-19 | 1990-07-17 | Kenneth B. McIntosh | Medication clock |
IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
US4811731A (en) * | 1985-07-30 | 1989-03-14 | Glaxo Group Limited | Devices for administering medicaments to patients |
SE453566B (sv) * | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
US4739754A (en) * | 1986-05-06 | 1988-04-26 | Shaner William T | Suction resistant inhalator |
US4790305A (en) * | 1986-06-23 | 1988-12-13 | The Johns Hopkins University | Medication delivery system |
US4926852B1 (en) * | 1986-06-23 | 1995-05-23 | Univ Johns Hopkins | Medication delivery system phase one |
DE3636669C2 (de) * | 1986-10-28 | 2001-08-16 | Siemens Ag | Anordnung zur Zufuhr von Aerosol zu den Luftwegen und/oder Lungen eines Patienten |
US5049388A (en) * | 1986-11-06 | 1991-09-17 | Research Development Foundation | Small particle aerosol liposome and liposome-drug combinations for medical use |
US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
NZ222907A (en) * | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
US5093316A (en) * | 1986-12-24 | 1992-03-03 | John Lezdey | Treatment of inflammation |
JP2656944B2 (ja) * | 1987-04-30 | 1997-09-24 | クーパー ラボラトリーズ | タンパク質性治療剤のエアロゾール化 |
IT1222509B (it) * | 1987-08-17 | 1990-09-05 | Miat Spa | Insufflatore per la somministrazione di farmaci sotto forma di polvere predosata in opercoli |
GB8723846D0 (en) * | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
US5081228A (en) * | 1988-02-25 | 1992-01-14 | Immunex Corporation | Interleukin-1 receptors |
WO1989004838A1 (en) * | 1987-11-25 | 1989-06-01 | Immunex Corporation | Interleukin-1 receptors |
US4968607A (en) * | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
IT1217890B (it) * | 1988-06-22 | 1990-03-30 | Chiesi Farma Spa | Dispositivo per l'inalazione di aerosol dosati |
EP0363060B1 (de) * | 1988-10-04 | 1994-04-27 | The Johns Hopkins University | Inhalationsgerät für Aerosolen |
US4984158A (en) * | 1988-10-14 | 1991-01-08 | Hillsman Dean | Metered dose inhaler biofeedback training and evaluation system |
DK479189D0 (da) * | 1989-01-06 | 1989-09-28 | Hans Gernot Schenk | Inhalator |
US5011678A (en) * | 1989-02-01 | 1991-04-30 | California Biotechnology Inc. | Composition and method for administration of pharmaceutically active substances |
IT1228459B (it) * | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
GB8904370D0 (en) * | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
SE466684B (sv) * | 1989-03-07 | 1992-03-23 | Draco Ab | Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator |
FI84698C (fi) * | 1989-06-16 | 1992-01-10 | Huhtamaeki Oy | Anordning foer finfoerdelning av agglomerat av en enkeldos av ett laekemedelpreparat i pulverform. |
IT1230313B (it) * | 1989-07-07 | 1991-10-18 | Somova Spa | Inalatore per medicamenti in capsule. |
DE3927170A1 (de) * | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
GB8918879D0 (en) * | 1989-08-18 | 1989-09-27 | Danbiosyst Uk | Pharmaceutical compositions |
US5238920A (en) * | 1989-08-22 | 1993-08-24 | Abbott Laboratories | Pulmonary surfactant protein fragments |
IT1237118B (it) * | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
US5376386A (en) * | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
GB9001635D0 (en) * | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
US5113855A (en) * | 1990-02-14 | 1992-05-19 | Newhouse Michael T | Powder inhaler |
DE4004904A1 (de) * | 1990-02-16 | 1990-09-13 | Gerhard Brendel | Trommel-applikator |
IT1243344B (it) * | 1990-07-16 | 1994-06-10 | Promo Pack Sa | Inalatore plurimonodose per medicamenti in polvere |
US5037912A (en) * | 1990-07-26 | 1991-08-06 | The Goodyear Tire & Rubber Company | Polymerization of 1,3-butadiene to trans-1,4-polybutadiene with organolithium and alkali metal alkoxide |
US5230884A (en) * | 1990-09-11 | 1993-07-27 | University Of Wales College Of Cardiff | Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
US5217004A (en) * | 1990-12-13 | 1993-06-08 | Tenax Corporation | Inhalation actuated dispensing apparatus |
US5099833A (en) * | 1991-02-19 | 1992-03-31 | Baxter International Inc. | High efficiency nebulizer having a flexible reservoir |
US5186164A (en) * | 1991-03-15 | 1993-02-16 | Puthalath Raghuprasad | Mist inhaler |
DE59107894D1 (de) * | 1991-03-21 | 1996-07-11 | Ritzau Pari Werk Gmbh Paul | Vernebler insbesondere zur Anwendung in Geräten für die Inhalationstherapie |
GB9106648D0 (en) * | 1991-03-28 | 1991-05-15 | Rhone Poulenc Rorer Ltd | New inhaler |
BR9106690A (pt) * | 1991-04-15 | 1993-06-29 | Huhtamaeki Yhthymae Oy | Disposicao para medir uma dose de medicamentos pulverulento para inalacao e aparelho de inalacao dotado do mesmo |
GB9116610D0 (en) * | 1991-08-01 | 1991-09-18 | Danbiosyst Uk | Preparation of microparticles |
US5161524A (en) * | 1991-08-02 | 1992-11-10 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means |
GB9123953D0 (en) * | 1991-11-12 | 1992-01-02 | Minnesota Mining & Mfg | Inhalation device |
US5378720A (en) * | 1991-12-19 | 1995-01-03 | Sterling Winthrop Inc. | Saccharin derivative proteolytic enzyme inhibitors |
AU653279B2 (en) * | 1991-12-30 | 1994-09-22 | Sanofi | Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
US5320094A (en) * | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
DE69306755T2 (de) * | 1992-01-21 | 1997-04-10 | Stanford Res Inst Int | Verbessertes verfahren zur herstellung von mikronisierter polypeptidarzneimitteln |
US5376359A (en) * | 1992-07-07 | 1994-12-27 | Glaxo, Inc. | Method of stabilizing aerosol formulations |
SK279327B6 (sk) * | 1992-10-19 | 1998-10-07 | Dura Pharmaceuticals | Zariadenie na vytváranie aerosolu z práškového lie |
US5364838A (en) * | 1993-01-29 | 1994-11-15 | Miris Medical Corporation | Method of administration of insulin |
US5641510A (en) * | 1994-07-01 | 1997-06-24 | Genentech, Inc. | Method for treating capsules used for drug storage |
US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
-
1996
- 1996-03-13 US US08/617,512 patent/US5780014A/en not_active Expired - Lifetime
- 1996-04-11 BR BR9609497A patent/BR9609497A/pt not_active Application Discontinuation
- 1996-04-11 MX MX9707854A patent/MX9707854A/es not_active IP Right Cessation
- 1996-04-11 AU AU54825/96A patent/AU703491B2/en not_active Ceased
- 1996-04-11 DE DE69631786T patent/DE69631786T3/de not_active Expired - Lifetime
- 1996-04-11 KR KR1019970707279A patent/KR100430125B1/ko not_active IP Right Cessation
- 1996-04-11 WO PCT/US1996/005062 patent/WO1996032152A1/en active IP Right Grant
- 1996-04-11 ES ES96911736T patent/ES2217309T5/es not_active Expired - Lifetime
- 1996-04-11 AT AT96911736T patent/ATE260688T1/de not_active IP Right Cessation
- 1996-04-11 CA CA002218208A patent/CA2218208A1/en not_active Abandoned
- 1996-04-11 EP EP96911736A patent/EP0866726B2/de not_active Expired - Lifetime
- 1996-04-11 JP JP8531208A patent/JPH10509738A/ja not_active Ceased
-
1998
- 1998-07-13 US US09/114,713 patent/US5993783A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2217309T5 (es) | 2008-06-01 |
KR100430125B1 (ko) | 2004-08-18 |
KR19980703879A (ko) | 1998-12-05 |
EP0866726A1 (de) | 1998-09-30 |
US5993783A (en) | 1999-11-30 |
US5780014A (en) | 1998-07-14 |
WO1996032152A1 (en) | 1996-10-17 |
CA2218208A1 (en) | 1996-10-17 |
DE69631786T2 (de) | 2005-03-10 |
ES2217309T3 (es) | 2004-11-01 |
BR9609497A (pt) | 1999-03-02 |
AU5482596A (en) | 1996-10-30 |
DE69631786T3 (de) | 2008-07-24 |
ATE260688T1 (de) | 2004-03-15 |
JPH10509738A (ja) | 1998-09-22 |
MX9707854A (es) | 1998-02-28 |
EP0866726A4 (de) | 1998-09-30 |
EP0866726B1 (de) | 2004-03-03 |
EP0866726B2 (de) | 2008-01-09 |
AU703491B2 (en) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69631786D1 (de) | Über die lungen verabreichbares trockenpulver alpha 1-antitrypsin | |
DK0663815T3 (da) | Inhalationspulvere og fremgangsmåde til fremstilling heraf | |
HUP0203885A2 (hu) | Új, tiotropium-tartalmú inhalációs por, eljárás az előállítására és alkalmazására | |
HUP0300499A2 (en) | Pharmaceutical formulations for dry powder inhalers | |
SE9701956D0 (sv) | New composition of matter | |
MX9404762A (es) | Composiciones para inhalacion y proceso para su preparacion. | |
KR0179378B1 (en) | Powder inhaler | |
MY115688A (en) | Pharmaceutical composition for administration by inhalation | |
EP0831782A4 (de) | Verfahren und system zur behandlung dispergierbarer feiner pulver | |
AP1861A (en) | Dry powder inhalation system for transpulmonary administration | |
FI960869A (fi) | Menetelmä aineiden konditioimiseksi | |
DK1019021T3 (da) | Stabiliserede præparater til anvendelse i inhalatorer med afmålt dosis | |
MX9605650A (es) | Formulaciones de propionato de fluticasona. | |
HUP0004053A2 (hu) | Eljárás haloterápia kivitelezésére | |
WO2003105775A3 (en) | DEHYDROEPIANDROSTERONE DIHYDRATE AND METHODS OF TREATING ASTHMA OR CHRONIC OBSTRUCTIVE PNEUMOPATHY USING COMPOSITIONS THEREOF | |
JPS6143389B2 (de) | ||
CY1113221T1 (el) | Διεργασια για την παρασκευη ενος φαρμακου | |
DE3583991D1 (de) | Arzneimittel enthaltend einen aus den peyer'schen plaques hergestellten organextrakt zur behandlung bei diabetes mellitus und pankreatitis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de | ||
8370 | Indication related to discontinuation of the patent is to be deleted | ||
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings |